← Browse by Condition
Medical Condition
esophageal squamous cell carcinoma
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 3, Phase 1
ClinicalMetric tracks all active clinical trials for esophageal squamous cell carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — esophageal squamous cell carcinoma Clinical Trials
How many clinical trials are currently recruiting for esophageal squamous cell carcinoma?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for esophageal squamous cell carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for esophageal squamous cell carcinoma?
esophageal squamous cell carcinoma research spans Phase 1 (1 trial), Phase 2 (3 trials), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a esophageal squamous cell carcinoma clinical trial?
Eligibility criteria for esophageal squamous cell carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 3
Phase 3 3
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05507411 Phase 2
Recruiting
Enrollment
100 pts
Location
China
Sponsor
Zhejiang Cancer Hospital
NCT04510129
Recruiting
Enrollment
1,650 pts
Location
United States
Sponsor
Cofactor Genomics, Inc.
NCT05919030 Phase 3
Recruiting
Enrollment
155 pts
Location
China
Sponsor
Renmin Hospital of Wuhan Unive...
NCT07284186 Phase 1
Recruiting
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT06644781 Phase 3
Recruiting
Enrollment
510 pts
Location
United States, Belgi...
Sponsor
Daiichi Sankyo
NCT06122493 Phase 2
Recruiting
Enrollment
48 pts
Location
China
Sponsor
Ruijin Hospital
NCT06561178
Recruiting
Enrollment
50 pts
Location
China
Sponsor
Sun Yat-Sen University Cancer ...
NCT06190782 Phase 3
Recruiting
Enrollment
354 pts
Location
China
Sponsor
Fudan University
NCT05563766 Phase 2
Recruiting
Enrollment
78 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT07088354
Recruiting
Enrollment
300 pts
Location
China
Sponsor
Tongji Hospital
Related Conditions
esophageal adenocarcinoma (2) cancer of head and neck (1) lung cancer nonsmall cell (1) small cell lung cancer (1) urothelial carcinoma (1) gastroesophageal junction adenocarcinoma (1) cervical cancer (1) triple negative breast cancer (1) hepatocellular carcinoma (1) renal cell carcinoma (1) colorectal cancer (1) gastric adenocarcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology